A southern New Jersey medical office claims to practice “rejuvenative” medicine, including cellulite reduction, skin tightening and plastic surgery, to name a few available treatments. Website photos of the center’s owner, a physician, show him lifting weights. As picture perfect as it all seems, this beauty-enhancing center has an ugly steroid problem.

The N.J. Board of Medical Examiners has suspended Dr. James Goodnight’s license after claiming that he allegedly prescribed steroids to patients, family members and himself, without providing sufficient care or full examinations, according to a published report. He was also cited for allowing nonmedical personnel to treat and care for patients and neglecting to keep detailed medical records. He was also cited for not safeguarding his prescription pad.

The physician’s practice, besides offering anti-aging medication and cosmetic surgery, also offered hormone therapy with testosterone. The physician, who consented to the board’s decision without denying or admitting to the claims, was suspended for six months and must enroll in medical ethics and medical practices courses. He must re-educate himself regarding proper medical practices.

New Jersey patients, whether seeking medical treatment for health concerns or cosmetic purposes, should be given the best care possible. They should not be given any medication or drug without undergoing a comprehensive examination. Patients should also be well informed about why they have to take a drug and its possible side effects.

Unnecessarily prescribing drugs to a patient can lead to complications and a worsened condition. Mt. Laurel, New Jersey, patients in a similar situation can file a medical malpractice lawsuit against a medical practitioner and the hospital or facility responsible for care. A patient can be awarded compensation to help cover damages and to help pay for corrective treatment, if needed.

Source: The Star-Ledger, “State suspends medical license of anti-aging doctor over steroids prescriptions,” Ted Sherman, Dec. 19, 2013